Severe hypoglycemia requiring medical intervention in a large cohort of adults with diabetes receiving care in U.S. Integrated health care delivery systems: 2005-2011. Diabetes care 2016;39:363-370

for the SUPREME-DM Study Group

doi:10.2337/dci16-0037

Severe hypoglycemia requiring medical intervention in a large cohort of adults with diabetes receiving care in U.S. Integrated health care delivery systems: 2005-2011. Diabetes care 2016;39:363-370

for the SUPREME-DM Study Group

School of Medicine

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	e26
Journal	Diabetes care
Volume	40
Issue number	2
DOIs	https://doi.org/10.2337/dci16-0037
State	Published - Feb 1 2017

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism
Advanced and Specialized Nursing

Access to Document

10.2337/dci16-0037

Cite this

@article{e60eb8a5dff7492183d053e3a6bf9996,

title = "Severe hypoglycemia requiring medical intervention in a large cohort of adults with diabetes receiving care in U.S. Integrated health care delivery systems: 2005-2011. Diabetes care 2016;39:363-370",

author = "{for the SUPREME-DM Study Group} and Pathak, {Ram D.} and Schroeder, {Emily B.} and Seaquist, {Elizabeth R.} and Chan Zeng and Lafata, {Jennifer Elston} and Abraham Thomas and Lawrence, {Jean M.} and Karter, {Andrew J.} and Steiner, {John F.} and Jodi Segal and O'Connor, {Patrick J.}",

note = "Funding Information: E.B.S. received industry sponsored research support from Novartis, Merck Sharpe & Dohme, Boehringer Ingelheim, AstraZeneca, and Bristol-Myers Squibb. E.R.S. served as a consultant for Sanofi. No other potential conflicts of interest relevant to this article were reported.",

year = "2017",

month = feb,

day = "1",

doi = "10.2337/dci16-0037",

language = "English (US)",

volume = "40",

pages = "e26",

journal = "Diabetes care",

issn = "0149-5992",

publisher = "American Diabetes Association Inc.",

number = "2",

}

TY - JOUR

T1 - Severe hypoglycemia requiring medical intervention in a large cohort of adults with diabetes receiving care in U.S. Integrated health care delivery systems

T2 - 2005-2011. Diabetes care 2016;39:363-370

AU - for the SUPREME-DM Study Group

AU - Pathak, Ram D.

AU - Schroeder, Emily B.

AU - Seaquist, Elizabeth R.

AU - Zeng, Chan

AU - Lafata, Jennifer Elston

AU - Thomas, Abraham

AU - Lawrence, Jean M.

AU - Karter, Andrew J.

AU - Steiner, John F.

AU - Segal, Jodi

AU - O'Connor, Patrick J.

N1 - Funding Information: E.B.S. received industry sponsored research support from Novartis, Merck Sharpe & Dohme, Boehringer Ingelheim, AstraZeneca, and Bristol-Myers Squibb. E.R.S. served as a consultant for Sanofi. No other potential conflicts of interest relevant to this article were reported.

PY - 2017/2/1

Y1 - 2017/2/1

UR - http://www.scopus.com/inward/record.url?scp=85011665190&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011665190&partnerID=8YFLogxK

U2 - 10.2337/dci16-0037

DO - 10.2337/dci16-0037

M3 - Comment/debate

C2 - 28108542

AN - SCOPUS:85011665190

SN - 0149-5992

VL - 40

SP - e26

JO - Diabetes care

JF - Diabetes care

IS - 2

ER -

Severe hypoglycemia requiring medical intervention in a large cohort of adults with diabetes receiving care in U.S. Integrated health care delivery systems: 2005-2011. Diabetes care 2016;39:363-370

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this